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In their analysis, the authors combined the results of two funda-
mentally different tests: dipyridamole echocardiography (DE) and
dobutamine stress echocardiography (DSE) and justify this by stating
that it has been made clear by a previous study from their group that
the two tests have “virtually identical diagnostic accuracy” (2). How-
ever, the cited study is a comparison in different patients of the two
stress modalities with the addition of atropine, whereas (although not
stated in the Methods section), the patients in the present study (1)
underwent DE without addition of atropine. Several studies (3)
comparing DE without addition of atropine and DSE in the same
patients have shown that the sensitivity for detection of coronary
disease is greater with DSE. As a result, the sensitivity of DSE (13
[76%] of 17) for a future MI tended to be better than that for DE (28
[53%] of 53). This tendency in favor of DSE is in agreement with a
recently published report (4) comparing the prognostic value of DSE
with that of adenosine echocardiography. Additionally, in patients with
ischemia during the test, the ischemia–infarction localization match
tended to be better for DSE (12 [92%] of 13) than for DE (20 [71%]
of 28).
In sharp contrast to the conclusions of the authors, the conclusions
of this study should be the following:
1. The majority of patients with a future MI had positive DSE results.
2. In virtually all patients with dobutamine-induced wall motion
abnormalities, a subsequent MI developed at the site of these
inducible wall motion abnormalities.
3. DSE seems to be more sensitive in predicting MI and more capable
of predicting the localization of this MI than DE.
Furthermore, it would be of great interest to know how many
patients of the total study group had ischemia on DE and DSE. If these
data are available, it would be interesting to know what the specificities
and predictive values of the respective tests were.
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Reply
We thank Geleijnse and Fioretti for their thoughtful comments on our
report. They question the opportunity of pooling together results
obtained from two different tests (dipyridamole and dobutamine–
atropine). In fact, the latter has a higher sensitivity for single-vessel
disease and the former a higher specificity (1), with a similar overall
accuracy of these two “fundamentally different” stress tests, which
happen to have an 80% concordance in detecting the presence and
location of stress-induced dysfunction (1). On the basis of the un-
proved assumption that higher sensitivity (but lower specificity) for
coronary artery disease could translate into greater prognostic power,
the authors calculate that dobutamine–atropine would have a higher
“sensitivity” for predicting reinfarction. Unfortunately, in our study
neither the selection criteria nor the sample size were adequate to
address this point because not all patients with myocardial infarction at
follow-up were selected, but only those with follow-up rest echocar-
diographic information available. This makes calculations of “sensitiv-
ity” (with no information on specificity) a perilous statistical (and
logical) somersault.
Geleijnse and Fioretti want to know whether stress-induced isch-
emia can predict reinfarction. Pharmacologic stress echocardiography
with dipyridamole can predict cardiac death much more strongly than
nonfatal reinfarction, which can be predicted with a relative risk of;2,
whereas the relative risk for death is ;4 (2). Regarding dobutamine–
atropine, in an updated preliminary analysis of the Echocardiography
Dobutamine International Cooperative study, nonfatal myocardial
infarction occurred in 11 of 436 patients with positive tests for
myocardial ischemia and in 13 of 342 patients with negative tests (2.5%
vs. 4%, p 5 NS), whereas peak wall motion score index was a
significant predictor of cardiac death (3). It seems that what is best for
diagnosis is not necessarily best for prognosis: More aggressive dosing
(e.g., combining atropine with dipyridamole or dobutamine) can
optimize the diagnostic performance for minor forms of coronary
artery disease, but it is also likely to increase the probability of
diagnosing more prognostically futile forms of the disease. Unfortu-
nately, “there are more things on heaven and earth [in human coronary
arteries], Horatio [Marcel and Paolo] that can be dreamt of in our
[pharmacologic stress echocardiographic] philosophy.” Plaque rup-
ture, inflammation and embolization are largely independent of plaque
size, which limits coronary flow reserve and determines pharmacologic
stress echocardiographic results. Vulnerable plaques are often angio-
graphically invisible, and a significant number of the disruption
episodes that precipitate infarction occur in coronary arteries that
were normal or mildly stenotic on a previous angiogram (4)—and to
recognize these plaques is asking too much even for third-generation
(atropine) stress echocardiographic testing. In addition, for any given
angiographic stenosis severity, a complex plaque morphology—more
prone to occlusion than a coronary stenosis with simple morpholo-
gy—is more likely to be associated with positivity on dipyridamole than
dobutamine–atropine stress testing (5–7).
To pretend to be able to see everything (all events) by stress
echocardiography is the best way to support skeptics pretending that
stress echocardiography can see nothing. In the real world, even the
“best” (i.e., most cost-effective) tests have their physiologic scotoma
(8), a blind spot that is tightly linked to the underlying physiologic
mechanisms of stress echocardiographic positivity.
ALBERT VARGA, MD
Albert Szent-Gyorgy Medical University
Second Department of Medicine
Szeged Koranyi
Fasor 6, H6720 Hungary
EUGENIO PICANO, MD, PHD
CNR Institute of Clinical Physiology
Via Savi 8
56100 Pisa, Italy
227JACC Vol. 29, No. 1 LETTERS TO THE EDITOR
January 1997:221–8
References
1. Pingitore A, Picano E. Dobutamine is better than dipyridamole for stress echocardiogra-
phy: an American tale? [abstract]. Circulation 1996;94 Suppl I:I-383.
2. Picano E, Pingitore A, Sicari R, et al. Stress echocardiography results predict the risk of
reinfarction early after acute uncomplicated myocardial infarction: large scale multicenter
study. J Am Coll Cardiol 1995;26:908–13.
3. Sicari R, Picano E, Landi P, et al. Prognostic value of dobutamine-atropine stress
echocardiography early after acute myocardial infarction. J Am Coll Cardiol. In press.
4. Davies MJ. Detecting vulnerable plaques. Lancet 1996;1422.
5. Lu C, Picano E, Pingitore A, et al.: Complex artery coronary lesion morphology influences
results of stress echocardiography. Circulation 1995;91:1669–1675.
6. Varga A, Pingitore A, Sicari R, et al. The relative role of coronary stenosis severity and
morphology in determining pharmacological stress echo positivity [abstract]. Eur Heart J
1996;538.
7. Beleslin B, Ostojic M, Djordievic-Dikic A, et al. Relationship between coronary lesion
morphology and induced myocardial ischemia during physical adrenergic and adenosiner-
gic stress: a “complex” link [abstract]. Eur Heart J 1996;538.
8. Picano E. Stress Echocardiography. 2nd ed. Heidelberg: Springer Verlag, 1996.
Measurement of Atrial Refractoriness
Dispersion: Is There a Better Way?*
The electrographic characteristic of atrial fibrillation and its correla-
tion with atrial refractoriness have been investigated recently by Li et
al. (1). This study, in my view, has indeed provided some useful
information to our current knowledge of the mechanism of atrial
fibrillation that has puzzled many investigators for years. In this article
(1), the duration of atrial fibrillation was found to correlate moderately
well with the atrial effective refractory period in the right posterior
lateral wall in a canine atrial fibrillation model established by rapid
atrial pacing. However, no significant relation between the duration of
the fibrillation and the dispersion of effective refractoriness was
documented. This result is obviously, as the authors point out (1), in
conflict with the study by Wang et al. (2) in which atrial refractoriness
dispersion was found to be the only predictor of duration of atrial
fibrillation. Also in conflict with the report by Li et al. is another study
in humans (3) in which increased atrial refractoriness dispersion was
responsible for the recurrence of atrial fibrillation. Li et al. (1)
assumed that their result differed with regard to the association of
fibrillation duration and local refractoriness dispersion because of the
different animal models that they used or because of some other
essentially unknown reasons. However, I suggest that the disparity
between their results and those of the other two studies may be largely
attributed to the technique they used to measure atrial refractoriness
and its dispersion.
The classical method for the measurement of atrial refractoriness,
as used by Li et al. (1), is to introduce an extrastimulus in progressively
shorter coupling intervals until the extrastimulus fails to generate an
atrial response. The major limitation of this technique is its inability to
detect the local refractoriness in multiple atrial sites simultaneously.
This technical drawback may have limited its role in the assessment of
the dispersion of atrial refractoriness. As an alternative, averaged local
fibrillation intervals have been used as an index for local refractoriness
(4), based on the assumption that during the fibrillation, cells regain
their excitability as soon as their refractory period ends. The atrial
refractoriness measured in this way has been shown to correlate well
with the effective refractory period determined by the classical extra-
stimulus technique in both animals (4) and humans (3). Although the
averaged atrial fibrillation interval is not necessarily a true refractory
period, and it can only be regarded as a limit of refractoriness, it
indeed allows the assessment of refractory period at multiple sites
simultaneously. It should be appreciated that atrial fibrillation interval
as an index of local atrial refractoriness is still far from widespread
clinical use; however, its application in experimental studies of refrac-
toriness or refractoriness dispersion may need to be encouraged.
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*The authors of the cited study have declined to prepare a response to this
letter.
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